The effect of Medicago Sativa syrup on the platelet count of patients with Idiopathic Thrombocytopenic Purpura
Phase 2
Recruiting
- Conditions
- Idiopathic Thrombocytopenic Purpura.Idiopathic Thrombocytopenic Purpura
- Registration Number
- IRCT2017010924993N2
- Lead Sponsor
- Research and Technology Vice-Chancellory of Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
the definitive diagnosis of ITP resistant to corticosteroids or corticosteroid dependent by an expert hematologist; platelet count between 50,000 to 150,000; aged between 15 and 50 years; lack of spontaneous bleeding; lack of other blood diseases; lack of systemic disease such as lupus erythematosus; lack of pregnancy; desire to attend the project
Exclusion criteria: an active and spontaneous bleeding; need to hospitalization; thrombocytopenia below 50,000; infectious disease; pregnancy
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Platelet count. Timepoint: Baseline, the end of the study. Method of measurement: Laboratory blood test.
- Secondary Outcome Measures
Name Time Method Complete Blood Count. Timepoint: Baseline, the end of the study. Method of measurement: Laboratory blood test.;Bleeding Time. Timepoint: Baseline, the end of the study. Method of measurement: Laboratory blood test.